Marshall Wace’s Enliven Therapeutics ELVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.69M | Buy |
333,333
+322,173
| +2,887% | +$6.46M | 0.01% | 925 |
|
|
2025
Q1 | $220K | Sell |
11,160
-30,222
| -73% | -$595K | ﹤0.01% | 2245 |
|
|
2024
Q4 | $931K | Sell |
41,382
-96,624
| -70% | -$2.17M | ﹤0.01% | 1642 |
|
|
2024
Q3 | $3.52M | Sell |
138,006
-54,094
| -28% | -$1.38M | ﹤0.01% | 1050 |
|
|
2024
Q2 | $4.49M | Buy |
+192,100
| New | +$4.49M | 0.01% | 943 |
|